UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: B | C | D | F | H | K | L | M | O | Q | S | T | U | X | Y
Number of items: 40.


Baxter, GF; Yellon, DM; (2003) Current trends and controversies in ischemia-reperfusion research--meeting report of the Hatter Institute 3rd International Workshop on Cardioprotection. Basic Res Cardiol , 98 (2) pp. 133-136.

Bell, RM; Cave, AC; Johar, I; Hearse, DJ; Shah, AM; Shattock, MJ; (2003) Ischemic preconditiong: Pivotal role of gp91(phox)-containing NADPH oxidase in oxidative signalling. In: (Proceedings) Fetzer-Institute Conference on Religiosity and Substance Use. (pp. A10-A10). ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD

Bell, RM; Cave, AC; Johar, S; Shah, AM; Shattock, MJ; (2003) The role of a gp91phox-containing NADPH oxidase in early ischemic preconditioning. In: (Proceedings) 76th Annual Scientific Session of the American-Heart-Association. (pp. pp. 46-47). LIPPINCOTT WILLIAMS & WILKINS

Bell, RM; Cave, AC; Shah, AM; Shattock, MJ; (2003) The essential role of gp91 phox-containing NADPH oxidase derived reactive oxygen species in early ischaemic preconditioning. In: (Proceedings) Annual Scientific Conference of the British-Cardiac-Society. (pp. A31-A31). B M J PUBLISHING GROUP

Bell, RM; Maddock, HL; Yellon, DM; (2003) The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart. CARDIOVASC RES , 57 (2) 405 - 415.

Bell, RM; Yellon, DM; (2003) Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. J AM COLL CARDIOL , 41 (3) 508 - 515. 10.1016/S0735-1097(02)02816-4.

Bell, RM; Yellon, DM; (2003) Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. J MOL CELL CARDIOL , 35 (2) 185 - 193.

Blauwet, LA; Edwards, WD; Tazelaar, HD; McGregor, CGA; (2003) Surgical pathology of pulmonary thromboendarterectomy: a study of 54 cases from 1990 to 2001. Hum Pathol , 34 (12) pp. 1290-1298. 10.1016/j.humpath.2003.07.003.


Chauhan, S; Rahman, A; Nilsson, H; Clapp, L; MacAllister, R; Ahluwalia, A; (2003) NO contributes to EDHF-like responses in rat small arteries: a role for NO stores. CARDIOVASC RES , 57 (1) 207 - 216.

Clapp, LH; Jabr, RI; (2003) The BK channel - Protective or detrimental in genetic hypertension? CIRC RES , 93 (10) 893 - 895. 10.1161/01.RES.0000103309.55054.3E.

Crestanello, JA; Zehr, KJ; McGregor, CGA; (2003) Pseudoaneurysm of the mammary to left anterior descending artery anastomosis after off-pump CABG. Eur J Cardiothorac Surg , 23 (2) 243-. 10.1016/s1010-7940(02)00723-6.

Cui, Y; Tinker, A; Clapp, LH; (2003) Different molecular sites of action for the K-ATP channel inhibitors, PNU-99963 and PNU-37883A. BRIT J PHARMACOL , 139 (1) 122 - 128.

Curtin, NA; West, TG; Ferenczi, MA; He, ZH; Sun, YB; Irving, M; Woledge, RC; (2003) Rate of actomyosin ATP hydrolysis diminishes during isometric contraction. Adv Exp Med Biol , 538 pp. 613-625. 10.1007/978-1-4419-9029-7_54.


D'Souza, SP; Yellon, DM; Baxter, GF; (2003) Cardioprotective action of type-B natriuretic peptide is NO-dependent. In: BRITISH JOURNAL OF PHARMACOLOGY. (pp. U11 - U11). NATURE PUBLISHING GROUP

D'Souza, SP; Yellon, DM; Martin, C; Schulz, R; Heusch, G; Onody, A; Ferdinandy, P; (2003) B-type natriuretic peptide limits infarct size in rat isolated hearts via K-ATP channel opening. AM J PHYSIOL-HEART C , 284 (5) H1592 - H1600. 10.1152/ajpheart.00902.2002.

Davidson, SM; Stephanou, A; Latchman, DS; (2003) FLIP protects cardiomyocytes from apoptosis induced by simulated ischemia/reoxygenation, as demonstrated by short hairpin-induced (shRNA) silencing of FLIP mRNA. J MOL CELL CARDIOL , 35 (11) 1359 - 1364. 10.1016/J.yjmcc.2003.08.001.


Fontaine, MJ; Winters, JL; Moore, SB; McGregor, CGA; Santrach, PJ; (2003) Frozen preoperative autologous blood donation for heart transplantation at the Mayo Clinic from 1988 to 1999. Transfusion , 43 (4) pp. 476-480. 10.1046/j.1537-2995.2003.00357.x.


Hausenloy, DJ; Duchen, MR; Yellon, DM; (2003) Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. CARDIOVASC RES , 60 (3) 617 - 625. 10.1016/j.cardiores.2003.09.025.

Hausenloy, DJ; Mocanu, MM; Yellon, DM; (2003) Activation of the pro-survival kinases (PI3 kinase-Akt and Erk 1/2) at reperfusion is essential for preconditioning-induced protection. In: CIRCULATION. (pp. 62 - 62). LIPPINCOTT WILLIAMS & WILKINS

Hausenloy, DJ; Wynne, AM; Duchen, MR; Yellon, DM; (2003) Transient mitochondrial permeability transition pore opening mediates ischemic preconditioning-induced protection. In: CIRCULATION. (pp. 220 - 220). LIPPINCOTT WILLIAMS & WILKINS

Hausenloy, DJ; Yellon, DM; (2003) The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J MOL CELL CARDIOL , 35 (4) 339 - 341. 10.1016/S0022-2828(03)00043-9.


Kanaan, N; Bachman, LA; McGregor, CGA; Griffin, MD; (2003) Porcine antigen presenting cells produce soluble adjuvants that stimulate B cells within and across the species. Am J Transplant , 3 (4) pp. 403-415.

Kis, A; Baxter, GF; Yellon, DM; (2003) Limitation of myocardial reperfusion injury by AMP579, an adenosine A(1)/A(2A) receptor agonist: Role of A(2A) receptor and Erk1/2. CARDIOVASC DRUG THER , 17 (5-6) 415 - 425.

Kis, A; Yellon, DM; Baxter, GF; (2003) Role of nuclear factor-kappa B activation in acute ischaemia-reperfusion injury in myocardium. BRIT J PHARMACOL , 138 (5) 894 - 900. 10.1038/sj.bjp.0705108.

Kis, A; Yellon, DM; Baxter, GF; (2003) Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase. J MOL CELL CARDIOL , 35 (9) 1063 - 1071. 10.1016/S0022-2828(03)00208-6.


Leung, T-C; Ballman, KV; Allison, TG; Wagner, JA; Olson, LJ; Frantz, RP; Edwards, BS; ... Rodeheffer, RJ; + view all (2003) Clinical predictors of exercise capacity 1 year after cardiac transplantation. J Heart Lung Transplant , 22 (1) pp. 16-27.


Martin, MJ; Yin, D; Adams, C; Houtz, J; Shen, J; Chong, AS; Sharma, A; ... Logan, JS; + view all (2003) Skin graft survival in genetically identical cloned pigs. Cloning Stem Cells , 5 (2) pp. 117-121. 10.1089/153623003322234713.

Mocanu, MM; Yellon, DM; (2003) Ischaemic preconditioning decreases the level of p53 via MDM2 phosphorylation in an isolated rat heart model. In: HEART. (pp. A14 - A15). B M J PUBLISHING GROUP

Mocanu, MM; Yellon, DM; (2003) Ischernic preconditioning and Mdm2 phosphorylation: Possible protection via p53 down-regulation. In: CIRCULATION. (pp. 274 - 274). LIPPINCOTT WILLIAMS & WILKINS

Mocanu, MM; Yellon, DM; (2003) p53 down-regulation: a new molecular mechanism involved in ischaemic preconditioning. FEBS LETT , 555 (2) 302 - 306. 10.1016/S0014-5793(03)01260-2.


O'Brien, AJ; O'Brien, AJ; Stidwill, R; Arrigoni, F; Singer, M; Clapp, L; (2003) LPS induces inos in all layers of rat mesenteric artery in both in vitro and in vivo models. In: INTENSIVE CARE MEDICINE. (pp. S133 - S133). SPRINGER-VERLAG


Quinn, KV; Cui, Y; Giblin, JP; Clapp, LH; Tinker, A; (2003) Do anionic phospholipids serve as cofactors or second messengers for the regulation of activity of cloned ATP-sensitive K+ channels? CIRC RES , 93 (7) 646 - 655. 10.1161/01.RES.0000095247.81449.8E. Green open access


Sack, MN; Yellon, DM; (2003) Insulin therapy as an adjunct to reperfusion after acute coronary ischemia - A proposed direct myocardial cell survival effect independent of metabolic modulation. J AM COLL CARDIOL , 41 (8) 1404 - 1407. 10.1016/S0735-1097(03)00164-5.

Sharma, A; Naziruddin, B; Cui, C; Martin, MJ; Xu, H; Wan, H; Lei, Y; ... Logan, JS; + view all (2003) Pig cells that lack the gene for alpha1-3 galactosyltransferase express low levels of the gal antigen. Transplantation , 75 (4) pp. 430-436. 10.1097/01.TP.0000053615.98201.77.

Smith, AN; Lovering, RC; Futai, M; Takeda, J; Brown, D; Karet, FE; (2003) Revised nomenclature for mammalian vacuolar-type H+-ATPase subunit genes. MOL CELL , 12 (4) 801 - 803.


Tsuruda, T; Jougasaki, M; Boerrigter, G; Costello-Boerrigter, LC; Cataliotti, A; Lee, SC; Salz-Gilman, L; ... Burnett, JC; + view all (2003) Ventricular adrenomedullin is associated with myocyte hypertrophy in human transplanted heart. Regul Pept , 112 (1-3) pp. 161-166.


Ugurlu, MM; Griffin, MD; Tazelaar, HD; McGregor, CGA; (2003) Synergistic effects of CTLA-4Ig and sirolimus on orthotopic lung-allograft survival and histology. Transplantation , 76 (3) pp. 489-495. 10.1097/01.TP.0000072374.48680.E0.


Xu, H; Sharma, A; Okabe, J; Cui, C; Huang, L; Wei, YY; Wan, H; ... Byrne, GW; + view all (2003) Serologic analysis of anti-porcine endogenous retroviruses immune responses in humans after ex vivo transgenic pig liver perfusion. ASAIO J , 49 (4) pp. 407-416.

Xu, H; Yin, D; Naziruddin, B; Chen, L; Stark, A; Wei, Y; Lei, Y; ... Chong, AS-F; + view all (2003) The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection. J Immunol , 170 (3) pp. 1531-1539. 10.4049/jimmunol.170.3.1531.


Yellon, DM; Downey, JM; (2003) Preconditioning the myocardium: From cellular physiology to clinical cardiology. PHYSIOL REV , 83 (4) 1113 - 1151. 10.1152/physrev.00009.2003.

This list was generated on Sun Aug 25 04:14:34 2019 BST.